Palantir's Post-Rally Crossroads: A Record Quarter Meets a Market Catching Its Breath

Palantir's Q2 revenue jumps 93% to $1.935B, beats estimates, lifts guidance, but stock cools after 30% surge; analysts split on valuation.

The numbers were staggering by any measure. Palantir Technologies closed out the second quarter of 2026 with revenue of $1.935 billion — a 93 percent year-over-year surge that left the consensus estimate of $1.81 billion in the dust. Adjusted earnings per share of $0.41 comfortably cleared analyst projections in the $0.34–$0.35 range, while GAAP net income hit $1.062 billion, translating to a 55 percent margin. Management responded by lifting full-year guidance to $8.150–$8.158 billion, the most aggressive upward revision in the company's history, and raised its adjusted free cash flow outlook to $4.5–$4.7 billion.

Wall Street's initial reaction was electric. The stock vaulted roughly 30 percent between the August 3 close and the August 4 settlement at $162.66, marking the biggest single-day gain since early 2024. But the euphoria has already begun to cool. In German trading on Wednesday, shares slipped 2.05 percent to €138.22, following a 2.82 percent decline the prior session. The pullback appears technically overdue: the Relative Strength Index sits at 68.8, flirting with overbought territory after a 19.30 percent run over just 30 days. Even after the surge, the stock remains 23.77 percent below its 52-week high of €179.98, set last November.

The Engine Room: US Commercial Momentum

The heart of the bull case lies in the US commercial segment, where the total contract value hit a record $2.132 billion in the quarter — a 153 percent jump from a year earlier. Revenue from US commercial customers expanded 149 percent to $764 million, outpacing the 90 percent growth in US government revenue to $809 million. The company also flagged a "Rule of 40" reading of 155 percent, powered by that 93 percent top-line growth and a 62 percent adjusted operating margin.

The question now is sustainability. Can triple-digit growth rates persist as the base expands, or will the law of large numbers inevitably assert itself? Any meaningful deceleration in these metrics would put immediate pressure on a valuation that remains the market's favorite debating point.

Street Reaction: Targets Move, But Not All in the Same Direction

The analyst community responded with a flurry of revisions, though the range of opinions reveals genuine disagreement. UBS lifted its target to $220 from $200 on August 4, maintaining a buy rating. Deutsche Bank upgraded the stock from Hold to Buy the same day, holding its target at $200. Citigroup's Tyler Radke reversed course dramatically, raising his target to $245 after having cut it to $200 just before earnings — the results, he argued, substantially weakened the bearish narrative around AI competition. DA Davidson's Gil Luria moved his target from $175 to $200 with a Buy rating, citing record commercial bookings. Rosenblatt Securities reaffirmed a $225 target, positioning Palantir as a primary beneficiary of global AI adoption.

Yet skepticism persists at the margins. Cantor Fitzgerald nudged its target to $156 while maintaining a neutral stance. Morningstar held firm on a $153 fair value estimate, citing a "narrow" economic moat and "very high" uncertainty. One house rates the stock neutral with a $156 target, well below current levels. The spread between the most optimistic and cautious targets — roughly $245 versus $153 — underscores how much of the debate hinges on whether the growth trajectory can justify the multiple.

The Tax Question Resurfaces

Adding a layer of political complexity, The Guardian reported Wednesday on an analysis by the Centre for International Corporate Tax Accountability and Research alleging Palantir paid just £2 million in UK corporate tax in 2024, despite holding public contracts worth around £670 million with the NHS and the Ministry of Defence. The group pegs Palantir's global effective tax rate at 1.4 percent. The timing is awkward: the company's deep ties to government clients already place it under heightened public scrutiny, and any regulatory escalation could become a genuine overhang.

What to Watch

Palantir's technical positioning offers a telling detail: the stock integrated Nvidia's Nemotron-Ultra models into its Artificial Intelligence Platform within 24 hours of their release in late June, with CEO Alex Karp citing five production tasks where the models outperformed established benchmarks. The company also disclosed a $10 million annual contract win with an unnamed major Silicon Valley technology firm, secured in direct competition with leading AI labs.

Institutional interest appears robust — Swedbank AB disclosed holdings of over 4 million shares at the end of Q2, while the New York State Common Retirement Fund reported nearly 2.4 million shares.

The next concrete test arrives November 2, 2026, when third-quarter results will reveal whether the summer's record pace can be sustained. As long as US commercial TCV growth remains in triple digits and guidance keeps climbing, the bulls likely retain control, treating pullbacks like this week's as a breather rather than a reversal. Should the growth engine sputter — or the tax controversy escalate into something more than a reputational headache — the valuation gap between Palantir's current price and the more cautious analyst targets leaves little room for error.